Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3043525	li-hsvab	— (—)	617	706	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Inflammatory diseases of the central nervous system

116

33.25

180.94

1.4

1.1

—

Viral infections of the central nervous system

29.10

143.57

1.3

1.2

—

Viral infections of the central nervous system, including avohilmo

27.24

143.39

1.3

1.2

—

Epilepsy

135

126

10.76

124.68

1.2

1.1

—

Convulsions, not elsewhere classified

14.76

109.28

1.2

—

Focal epilepsy

103

105

9.89

89.77

1.2

1.1

—

Focal epilepsy, strict definition

10.30

88.79

1.2

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

10.31

84.37

1.2

1.1

—

Meningitis

31.36

84.09

1.4

1.2

—

Headache

149

187

6.17

78.44

1.1

—

Fever of other and unknown origin

133

185

6.24

74.36

1.2

1.1

—

Other symptoms and signs involving cognitive functions and awareness

139

217

5.70

71.63

1.2

1.1

—

Status epilepticus

31.56

65.75

1.3

1.1

—

General symptoms and signs

191

210

4.56

61.14

1.2

1.1

—

Neurological diseases

132

6.77

60.67

1.2

1.0

—

Encephalitis

78.93

59.71

1.4

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

203

353

3.85

59.71

1.2

1.1

—

Other encephalitis

87.67

59.64

1.4

1.1

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

73.10

53.97

1.4

1.2

—

Cerebrovascular diseases

167

284

4.09

53.87

1.2

—

Intracranial trauma

8.06

53.70

1.1

1.0

—

Viral encephalitis, not elsewhere classified/unspecified

71.96

52.98

1.4

1.2

—

Malaise and fatigue

108

155

5.50

51.33

1.1

—

Certain infectious and parasitic diseases

153

177

4.34

46.44

1.1

—

Sequelae of cerebrovascular disease

165

5.14

45.28

1.2

1.1

—

Concussion

7.55

44.77

1.1

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

111

6.53

44.54

1.1

1.2

—

Bacterial infection, other or unspecified, including avohilmo

137

294

3.83

43.00

1.2

1.1

—

Bacterial infection, other or unspecified

127

270

3.98

42.41

1.2

1.1

—

Other degenerative diseases of the nervous system

9.93

39.38

1.2

1.1

—

Abnormal findings on diagnostic imaging of central nervous system

14.38

37.40

1.4

1.3

—

Implicit Sepsis, including avohilmo

156

344

3.24

36.90

1.2

1.1

—

Speech disturbances, not elsewhere classified

9.26

36.54

1.2

1.1

—

Implicit Sepsis

148

333

3.28

35.95

1.2

1.1

—

Cerebrovascular diseases (FINNGEN)

102

5.45

35.53

1.1

—

Stroke, excluding SAH

127

256

3.59

35.06

1.2

—

Other and unspecified polyneuropathies, also in other diseases

100

6.03

34.43

1.1

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

155

343

3.13

34.43

1.2

1.1

—

Stroke, including SAH

129

266

3.49

34.13

1.2

1.1

—

Episodal and paroxysmal disorders

165

263

3.19

33.79

1.2

1.1

—

Anaemias

9.45

33.44

1.2

1.0

—

Medical observation and evaluation for suspected diseases and conditions

115

143

4.12

33.33

1.2

1.1

—

Neurological diseases, wide definition

14.46

32.53

1.2

1.1

—

Implicit viral Sepsis

5.88

32.49

1.2

1.1

—

Viral Sepsis

5.88

32.49

1.2

1.1

—

Spirochaetal infections, other/unspecified

8.32

32.10

1.1

—

Other bacterial diseases

167

384

2.88

31.86

1.2

1.1

—

Bacterial Sepsis

100

217

3.82

31.52

1.2

1.1

—

Continuous positive airway pressure

6.88

30.79

1.2

1.1

—

Implicit viral Sepsis, including avohilmo

157

4.59

30.57

1.2

1.1

—

Implicit bacterial Sepsis

201

3.93

30.56

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

153

352

2.94

30.33

1.2

1.1

—

Visual disturbances and blindness

109

330

3.31

29.29

1.2

1.1

—

Infections, IBD-co-morbidities

17.62

29.08

1.3

1.1

—

Implicit bacterial Sepsis, including avohilmo

215

3.68

28.57

1.2

1.1

—

Ischaemic Stroke, excluding all haemorrhages

114

252

3.34

28.55

1.2

—

Delirium, not induced by alcohol and other psychoactive substances

7.22

27.85

1.2

—

STROKE

105

207

3.42

26.57

1.2

1.1

—

Dizziness and giddiness

121

314

3.00

26.01

1.1

—

Other neurological diseases

132

363

2.82

25.49

1.2

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

110

366

3.01

25.34

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

170

366

2.58

25.27

1.2

1.1

—

Pneumonia, organism unspecified

152

397

2.63

24.83

1.2

1.1

—

Migraine

158

3.85

24.48

1.2

1.1

—

Other bacterial diseases, including avohilmo

157

384

2.55

23.66

1.2

1.1

—

Pneumonitis due to solids and liquids

8.22

23.50

1.3

1.2

—

Influenza and pneumonia

165

412

2.47

23.23

1.2

1.1

—

ILD medications

170

372

2.46

22.85

1.2

1.1

—

All kidney diseases

157

425

2.48

22.70

1.1

—

ILD medications: immunosuppressive drugs

105

332

2.87

21.77

1.2

1.1

—

Visual disturbances

303

3.04

21.67

1.1

—

GASTRO-related operations

100

154

3.26

21.33

1.1

—

Any gastric operation

100

154

3.26

21.33

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

154

425

2.41

21.12

1.2

1.1

—

Certain infectious and parasitic diseases, including avohilmo

132

3.42

20.57

1.2

1.1

—

Paralytic strabismus

8.25

20.51

1.1

1.2

—

Persons encountering health services in other circumstances

250

3.17

20.20

1.1

—

All pneumoniae

155

427

2.36

20.13

1.2

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

154

426

2.36

20.08

1.2

1.1

—

134

307

2.55

19.90

1.2

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

134

307

2.55

19.90

1.2

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

143

3.27

19.59

1.2

1.1

—

Diseases of the myoneural junction and muscle

5.55

19.58

1.2

—

Viral meningitis

24.96

19.56

1.5

1.4

—

Other spirochaetal diseases

199

3.43

19.48

1.1

—

Syncope and collapse

142

3.71

19.32

1.2

1.1

—

Spirochaetal infections, other/unspecified, including avohilmo

198

3.39

18.92

1.1

—

Other spirochaetal diseases, including avohilmo

203

3.36

18.90

1.1

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

150

438

2.31

18.79

1.2

1.1

—

Lyme disease

199

3.38

18.77

1.1

—

Lyme disease, including avohilmo

199

3.38

18.77

1.1

—

First line medication for Crohn's disease

156

361

2.33

18.67

1.2

1.1

—

Viral meningitis, including avohilmo

21.11

18.64

1.5

1.3

—

Oedema, not elsewhere classified

119

4.11

18.49

1.3

1.1

—

Organic, including symptomatic, mental disorders

242

2.82

18.40

1.2

—

Inflammatory bowel disease treatment related agents

166

412

2.24

18.35

1.2

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6.44

18.33

1.2

1.1

—

Hydrocephalus

7.48

18.23

1.1

1.2

—

Bacterial meningitis

22.06

18.21

1.3

1.1

—

Oral corticosteroids

157

407

2.26

18.12

1.2

1.1

—

Renal tubulo-interstitial diseases

133

420

2.32

17.26

1.2

—

Other antidepressants

147

324

2.32

17.22

1.2

1.1

—

Other headache syndromes

171

3.44

17.09

1.2

1.1

—

Explicit Sepsis

223

3.03

17.00

1.1

—

Explicit Sepsis, including avohilmo

232

2.97

16.92

1.1

—

Autoimmune diseases excluding thyroid diseases

151

366

2.24

16.66

1.1

1.2

—

Lung diseases due to external agents

5.26

16.52

1.2

—

Other disorders of fluid, electrolyte and acid-base balance

183

3.25

16.42

1.1

—

Injuries to the head

159

442

2.14

16.11

1.1

1.2

—

Symptoms and signs involving the urinary system

119

382

2.35

16.04

1.1

1.2

—

Viral infections characterized by skin and mucous membrane lesions

258

2.87

15.86

1.3

1.1

—

Hypo-osmolality and hyponatraemia

4.24

15.48

1.1

1.2

—

Nausea and vomiting

136

3.59

15.37

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

143

2.94

15.30

1.2

1.1

—

Any death

102

287

2.49

15.25

1.1

1.2

—

Other and unspecified myopathies

5.90

15.24

1.1

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

107

396

2.35

14.95

1.2

1.1

—

Cerebral palsy and other paralytic syndromes

5.39

14.93

1.3

1.2

—

Symptoms and signs involving speech and voice

198

3.09

14.88

1.2

1.1

—

Septicaemia

219

2.88

14.57

1.1

—

Oxycodone

228

2.78

14.46

1.1

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

142

359

2.15

14.40

1.1

1.2

—

Pain in joint

196

2.67

14.09

1.2

1.1

—

Autoimmune diseases related-to ILD

123

476

2.16

13.95

1.1

1.2

—

Other septicaemia, including avohilmo

208

2.89

13.77

1.1

—

Acute tubulo-interstitial nephritis

356

2.35

13.74

1.2

—

Diplopia

4.59

13.74

1.1

—

Abnormalities of gait and mobility

4.65

13.50

1.1

1.2

—

Intracranial injury

354

2.40

13.50

1.1

1.2

—

Benzodiazepine use

141

464

2.05

13.42

1.1

1.2

—

Other diseases of urinary system

136

362

2.11

13.29

1.2

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

256

2.70

13.26

1.1

—

Tramadol

109

287

2.28

13.12

1.1

1.2

—

Diagnoses used for exclusion with ILD

141

3.34

13.08

1.2

—

Presence of other devices

129

3.44

13.05

1.2

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

117

3.55

12.80

1.1

—

Systemic connective tissue disorders

207

2.86

12.62

1.2

1.1

—

Iron deficiency anaemia

269

2.59

12.57

1.2

1.1

—

Other septicaemia

206

2.80

12.40

1.1

—

Herpesviral [herpes simplex] infections

4.55

12.34

1.3

1.1

—

Zoster [herpes zoster]

103

3.70

12.33

1.3

1.1

—

Used for control exclusion in common control thyroid runs

134

327

2.07

12.12

1.1

—

Nerve, nerve root and plexus disorders

146

446

1.97

12.10

1.2

1.1

—

Dorsalgia

134

346

2.05

12.07

1.1

—

Low back pain

109

339

2.17

12.04

1.2

1.1

—

Other specific joint derangements/joint disorders

106

299

2.21

11.98

1.1

—

Bleeding

119

401

2.08

11.93

1.1

1.2

—

Dysphagia

135

3.27

11.85

1.1

—

Guillain-Barre syndrome

30.68

11.69

1.1

1.6

—

Other and unspecified iron deficiency

211

2.75

11.58

1.2

1.1

—

Persons encountering health services for examination and investigation

143

2.63

11.47

1.1

—

Enlarged lymph nodes

5.01

11.44

1.1

1.2

—

Diseases of the eye and adnexa

209

2.30

11.23

1.1

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

128

406

1.99

11.18

1.2

1.1

—

Second line medication for Crohn's disease

372

2.26

11.10

1.2

1.1

—

Provisional assignment of new diseases of uncertain etiology

333

2.32

11.02

1.2

1.1

—

Codes for special purposes

333

2.32

11.02

1.2

1.1

—

Examination and observation for other reasons

142

2.66

10.91

1.3

1.1

—

Fall on same level

147

411

1.91

10.90

1.1

1.2

—

Opioids

122

308

2.05

10.88

1.1

1.2

—

COPD/asthma related infections

124

307

2.02

10.67

1.2

1.1

—

COPD/asthma/ILD related infections

124

307

2.02

10.67

1.2

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

184

2.43

10.64

1.2

1.1

—

Cardiovascular diseases

150

2.55

10.59

1.2

1.1

—

Strabismus

150

3.00

10.54

1.2

1.1

—

ILD medications: azathioprine

4.23

10.53

1.2

—

Other reaction to severe stress, and adjustment disorders

194

2.73

10.52

1.1

1.2

—

Glomerular disorders in diseases classified elsewhere

4.48

10.47

1.1

1.2

—

L04AX Other immunosuppressants

363

2.23

10.45

1.2

1.1

—

Visual impairment including blindness (binocular or monocular)

7.71

10.37

1.3

1.2

—

Moderate visual impairment, binocular

16.19

10.36

1.2

1.4

—

Other disorders of urethra and urinary system

309

2.14

10.27

1.2

1.1

—

All influenza

132

3.11

10.25

1.1

—

Complications of surgical and medical care, not elsewhere classified

132

465

1.89

10.16

1.1

—

Depression medications

4.46

10.01

1.2

1.0

—

Autoimmune diseases

137

368

1.89

9.82

1.1

1.2

—

Alzheimer disease, excluding more controls

6.48

9.78

1.3

1.0

—

Exclusions for E4_PCOS_BROAD

3.52

9.73

1.3

1.1

—

Codeine

113

305

2.00

9.70

1.1

1.2

—

Other dorsopathies, not elsewhere classified

128

346

1.92

9.70

1.1

—

Parasetamol

181

2.29

9.59

1.1

—

Disorders of thyroid, IBD co-morbidities

10.85

9.52

1.1

—

Bell's palsy

4.01

9.49

1.1

—

Nutritional anaemias

317

2.23

9.46

1.2

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

119

491

1.89

9.39

1.2

1.1

—

Insulin medication

333

2.12

9.36

1.2

1.1

—

Fitting and adjustment of other devices

216

2.45

9.35

1.1

1.2

—

Complications of medical and surgical care

100

454

1.98

9.33

1.2

1.1

—

Any mental disorder

132

352

1.88

9.29

1.2

1.1

—

Antihypertensive medication - note that there are other indications

161

2.37

9.29

1.2

1.1

—

Traumatic subdural haemorrhage

8.15

9.29

1.1

1.0

—

Unspecified urinary incontinence

4.69

9.28

1.1

1.2

—

Glomerular diseases

3.34

9.28

1.1

1.2

—

Other soft tissue disorders, not elsewhere classified

119

352

1.92

9.27

1.1

1.2

—

Azathioprine

3.81

9.21

1.2

—

Covid-19 confirmed case

228

2.46

9.03

1.3

1.1

—

Anxiety disorders, excluding more controls

100

319

2.00

9.00

1.1

—

Migraine without aura

3.64

8.96

1.1

—

Other demyelinating diseases of the central nervous system

12.61

8.87

1.1

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

456

1.97

8.81

1.2

1.1

—

Neurotic, stress-related and somatoform disorders

111

402

1.90

8.78

1.1

—

Parkinson's disease, excluding more controls

8.73

8.71

1.1

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.55

8.65

1.1

—

Zoster [herpes zoster], including avohilmo

340

2.13

8.65

1.2

1.1

—

Dementia, including avohilmo

216

2.24

8.64

1.1

1.2

—

Migraine with aura

3.24

8.58

1.2

1.1

—

Other viral diseases

169

2.66

8.53

1.2

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

381

2.02

8.49

1.2

1.1

—

Heart failure, not strict

340

1.96

8.48

1.1

1.2

—

Cystitis

104

319

1.94

8.44

1.2

1.1

—

Anxiety disorders

111

406

1.88

8.44

1.1

—

Demyelinating diseases of the central nervous system

4.30

8.39

1.0

1.2

—

Psychiatric diseases

115

304

1.90

8.36

1.2

1.1

—

Falls/tendency to fall

125

340

1.84

8.35

1.1

1.2

—

Visual field defects

4.65

8.34

1.1

1.2

—

Parkinson's disease, strict definition, excluding more controls

8.83

8.33

1.1

1.0

—

Insulin, intermediate and long-acting

358

2.08

8.33

1.2

1.1

—

Dementia

194

2.29

8.33

1.1

—

Pain, not elsewhere classified

3.38

8.32

1.2

1.1

—

Cervicalgia

112

3.04

8.25

1.3

1.2

—

Special screening examination for infectious and parasitic diseases

3.48

8.24

1.2

1.1

—

Exposure to other specified factors

104

477

1.87

8.22

1.2

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

117

2.68

8.21

1.0

1.1

—

Nontraumatic intracranial haemmorrhage

3.27

8.18

1.0

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

6.49

8.17

1.2

—

COPD differential diagnosis

198

2.10

7.99

1.2

1.1

—

ILD differential diagnosis

198

2.10

7.99

1.2

1.1

—

Sleep apnoea

119

415

1.81

7.95

1.1

—

Other disorders of lacrimal gland

243

2.31

7.92

1.2

1.1

—

Complications of procedures, not elsewhere classified

104

452

1.85

7.90

1.1

—

Other systemic involvement of connective tissue (FG)

134

2.79

7.89

1.2

1.1

—

Other viral diseases, including avohilmo

217

2.38

7.84

1.2

1.1

—

Excluding asthma or asthma-COPD overlap

197

2.09

7.77

1.2

1.1

—

Symptoms and signs involving the digestive system and abdomen

117

320

1.83

7.73

1.2

—

Brain glioblastoma and astrocytoma

15.22

7.73

1.2

1.6

—

Unspecified fall

336

2.08

7.73

1.1

—

Presence of other functional implants

265

2.04

7.68

1.1

1.2

—

Intestinal infectious diseases

118

495

1.77

7.66

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

162

2.60

7.65

1.1

—

Cervical disc disorders

216

2.36

7.64

1.1

1.2

—

Third [oculomotor] nerve palsy

18.59

7.62

1.1

1.7

—

Herpesviral [herpes simplex] infections, including avohilmo

140

2.72

7.57

1.3

1.1

—

Hard cardiovascular diseases

309

1.89

7.54

1.1

—

Insulin, fast-acting

211

2.37

7.54

1.2

—

Type 1 diabetes

135

2.74

7.49

1.1

—

Disturbances of skin sensation

164

2.57

7.48

1.1

—

Disorders of lacrimal system

283

2.16

7.47

1.2

1.1

—

Urinary track infection

157

2.20

7.46

1.2

1.1

—

Other pulmonary diagnosis

197

2.06

7.46

1.2

1.1

—

Malignant neoplasm of brain, including Hilmo

7.67

7.38

1.1

1.3

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

5.97

7.36

1.1

1.3

—

All chronic kidney diseases

285

2.04

7.36

1.1

1.2

—

Polycystic ovarian syndrome, consortium definition

239

1.99

7.27

1.2

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

296

2.11

7.21

1.2

—

Chronic kidney disease

195

2.37

7.20

1.1

—

Other mental disorders due to brain damage and dysfunction and to physical disease

3.68

7.17

1.2

—

Other necrotizing vasculopathies

4.49

7.17

1.4

1.2

—

Other systemic involvement of connective tissue

156

2.57

7.15

1.2

1.1

—

Insulin, fast-acting or short human

223

2.29

7.12

1.2

—

Budesonide

3.44

7.10

1.3

1.2

—

Any reimbursement code in KELA

135

2.27

7.06

1.1

—

Sixth [abducent] nerve palsy

10.09

7.04

1.1

1.4

—

Malignant neoplasm of brain

10.08

7.03

1.2

1.5

—

Other CVD (FINNGEN)

4.13

7.02

1.1

—

Other external causes of accidental injury

237

1.92

7.00

1.2

1.1

—

Secondary hypertension

5.93

6.97

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

416

1.87

6.95

1.1

—

Generalized anxiety disorder

3.29

6.93

1.2

—

Mood disorders, excluding more controls

106

347

1.80

6.89

1.1

—

Hypertensive diseases (excluding secondary)

158

2.21

6.86

1.1

—

Substance abuse, excluding more controls

280

2.03

6.83

1.2

1.1

—

Liquid cancers

173

2.41

6.83

1.2

—

Follow-up care involving plastic surgery

8.30

6.83

1.1

1.4

—

Malignant neoplasm of eye, brain and central nervous system

8.29

6.82

1.1

1.4

—

Cellulitis

131

2.68

6.80

1.3

1.1

—

Brain glioblastoma

16.94

6.76

1.2

1.3

—

Brain glioblastoma, helper endpoint

16.94

6.76

1.2

1.3

—

Disorders of speech understanding and production

8.13

6.73

1.6

1.3

—

Metabolic disorders

111

380

1.75

6.70

1.2

1.1

—

Abnormalities of heart beat

222

2.23

6.69

1.2

1.1

—

Disorders of choroid and retina

103

407

1.77

6.67

1.1

—

Sleep disorders (combined)

128

395

1.69

6.64

1.2

1.1

—

Other necrotizing vasculopathies (FG)

6.43

6.63

1.4

1.2

—

Intestinal infectious diseases, including avohilmo, including avohilmo

135

453

1.66

6.61

1.1

1.2

—

Other symptoms and signs involving general sensations and perceptions

12.29

6.58

1.0

1.4

—

Mycoses

157

2.49

6.56

1.3

1.1

—

Exposure to unspecified factor

122

493

1.68

6.56

1.1

1.2

—

Disorders of other endocrine glands

267

2.10

6.49

1.2

1.1

—

Pain (limb, back, neck, head abdominally)

198

1.97

6.48

1.1

—

Other viral diseases, not elsewhere classified

101

2.87

6.41

1.2

1.1

—

Disorders of lens

264

1.90

6.41

1.2

—

Type 2 diabetes, wide definition

342

1.79

6.36

1.1

1.2

—

Retention of urine

171

2.27

6.36

1.2

—

Other functional intestinal disorders

284

2.02

6.34

1.1

—

Cerebral cysts

6.55

6.33

1.1

1.3

—

Polyarthropathies

280

1.88

6.32

1.1

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

113

327

1.73

6.31

1.1

—

Disorders of optic nerve and visual pathways

3.58

6.30

1.2

1.1

—

Other and unspecified degenerative diseases of nervous system

11.10

6.30

1.1

—

Accidents

237

1.86

6.19

1.2

1.1

—

Pain in limb

348

1.77

6.18

1.2

—

Subjective visual disturbances

144

2.50

6.16

1.1

—

Liquid cancers, including Hilmo

202

2.18

6.16

1.1

1.2

—

Recurrent or chronic depression

125

2.39

6.15

1.2

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

409

1.85

6.09

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

119

459

1.66

6.09

1.1

1.2

—

Infections of the skin and subcutaneous tissue

397

1.86

6.07

1.2

1.1

—

Disorders of psychological development

3.80

6.05

1.5

1.2

—

Factors influencing health status and contact with health services

2.92

6.04

1.2

1.1

—

Early onset COPD, excluding more controls

3.01

6.04

1.4

1.1

—

Disorders of eyelid, lacrimal system and orbit

104

446

1.71

6.04

1.2

1.1

—

L04AA Selective immunosuppressants

128

2.58

6.02

1.2

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

140

2.50

6.00

1.1

1.2

—

Intracerebral haemorrhage

3.46

5.99

1.0

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

5.54

5.98

1.2

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.98

5.94

1.2

1.1

—

Senile cataract

240

1.90

5.92

1.2

—

Sleep apnoea, including avohilmo

119

435

1.65

5.91

1.1

—

Speech and linguistic disorders, excluding more controls

6.58

5.90

1.6

1.3

—

Abdominal and pelvic pain

109

320

1.71

5.87

1.1

1.2

—

Selective serotonin reuptake inhibitors

107

325

1.71

5.83

1.2

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

378

1.76

5.83

1.2

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.74

5.82

1.0

1.1

—

Other disorders of eye and adnexa

3.01

5.79

1.3

1.1

—

Conductive and sensorineural hearing loss

363

1.74

5.76

1.1

1.2

—

Gastrointestinal diseases

169

1.99

5.72

1.1

—

Persons encountering health services in other circumstances, wide

128

407

1.62

5.64

1.1

—

Diabetes medication

118

421

1.64

5.62

1.1

—

Non-Hodgkin lymphoma, all, including Hilmo

3.11

5.60

1.1

1.2

—

Impacted cerumen

3.19

5.58

1.1

1.2

—

Gastro-oesophageal reflux disease

409

1.75

5.57

1.2

1.1

—

Missing teeth due to accident, extraction or parodontitis

395

1.79

5.57

1.3

1.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

8.53

5.56

1.1

1.3

—

Chronic lymphocytic leukaemia

8.53

5.56

1.1

1.3

—

Chronic lymphocytic leukaemia, helper endpoint

8.53

5.56

1.1

1.3

—

Acute sinusitis

280

1.95

5.55

1.3

1.1

—

Other heart diseases

156

2.13

5.54

1.1

—

Other disorders of skin and subcutaneous tissue

435

1.73

5.54

1.1

—

Type 1 diabetes, wide definition, subgroup 1

110

2.64

5.54

1.2

1.1

—

Normal-pressure hydrocephalus

5.87

5.53

1.1

1.3

—

Abnormalities of breathing

327

1.71

5.51

1.2

1.1

—

Specific development disorders of speech and language

5.89

5.51

1.6

1.3

—

Migraine without aura and triptan purchases

2.85

5.50

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

333

1.88

5.49

1.1

—

Abnormal findings on diagnostic imaging of lung

307

1.91

5.48

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

6.50

5.45

1.2

1.0

—

Vitamin deficiency, wide

7.09

5.43

1.1

1.3

—

Vitamin deficiency

7.09

5.43

1.1

1.3

—

Aneurysms, operations, SAH

2.95

5.40

1.1

1.2

—

Other viral diseases, not elsewhere classified, including avohilmo

159

2.32

5.39

1.2

1.1

—

Other medical care

278

1.90

5.37

1.1

1.2

—

Care involving dialysis

3.73

5.36

1.2

—

Finngen Rheumatological endpoints

106

362

1.66

5.34

1.2

1.1

—

External causes of morbidity and mortality

188

1.89

5.32

1.2

—

Diabetic maculopathy, excluding more controls

3.40

5.30

1.2

—

Other retinal disorders

339

1.77

5.28

1.1

1.2

—

Sensorineural hearing loss

345

1.72

5.25

1.1

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

5.94

5.22

1.1

1.3

—

Diffuse large B-cell lymphoma, including Hilmo

5.94

5.22

1.1

1.3

—

Diffuse large B-cell lymphoma

5.94

5.22

1.1

1.3

—

Diseases of the musculoskeletal system and connective tissue

144

2.02

5.21

1.1

1.2

—

Transplanted organ and tissue status

3.65

5.19

1.3

1.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

182

2.20

5.19

1.1

—

Myalgia

138

2.39

5.19

1.1

—

Other joint disorders

306

1.69

5.18

1.2

1.1

—

Dorsopathies

112

347

1.63

5.17

1.1

—

N06DA Anticholinesterases

173

2.10

5.16

1.1

—

Use of anticholinesterases

173

2.10

5.16

1.1

—

Diseases of the respiratory system

169

1.93

5.15

1.2

1.1

—

Lower back pain or/and sciatica

123

486

1.57

5.09

1.2

1.1

—

Diabetic retinopathy, excluding more controls

2.43

5.09

1.1

—

Nystagmus and other irregular eye movements

13.50

5.09

1.3

1.7

—

Conjunctivitis (acute, non atopic)

164

2.25

5.06

1.1

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

217

2.08

5.06

1.2

1.1

—

Extrapyramidal and movement disorders

244

2.01

5.06

1.1

—

Inflammatory diseases of female pelvic organs

258

1.83

5.05

1.2

1.1

—

Codeine or tramadol medication

127

440

1.57

5.05

1.1

—

Aplastic and other anaemias

292

1.88

5.04

1.1

1.2

—

Diabetic retinopathy, strict definition

2.69

5.04

1.2

1.1

—

Anaemia in chronic diseases classified elsewhere

10.08

5.03

1.1

1.4

—

Diabetes mellitus

114

411

1.60

5.02

1.1

—

Heartburn

3.41

5.02

1.2

1.1

—

Type 1 diabetes, wide definition

116

2.50

5.01

1.2

1.1

—

Endocrine, nutritional and metabolic diseases

238

1.76

5.01

1.1

—

Arthropathies

101

307

1.66

4.99

1.1

—

MS-disease / Multiple Sclerosis

4.70

4.98

1.0

1.2

—

Osteopathies and chondropathies

359

1.78

4.97

1.1

1.2

—

Certain disorders involving the immune mechanism

105

2.58

4.95

1.3

1.1

—

Hypoglycaemia, other or unspecified

5.02

4.93

1.3

—

Insulin, fast-acting (human)

3.04

4.93

1.2

—

Diseases of external ear

233

2.02

4.92

1.2

—

Hemiplegia

6.03

4.91

1.1

1.3

—

Transient ischemic attack

249

1.89

4.90

1.2

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

403

1.76

4.88

1.1

—

Other disorders of patella

2.78

4.86

1.2

—

Abnormal involuntary movements

2.92

4.86

1.1

1.2

—

Sequelae of infectious and parasitic diseases, including avohilmo

4.56

4.86

1.3

1.2

—

Type of accident

168

2.21

4.85

1.1

—

Diabetes, varying definitions

113

412

1.59

4.85

1.1

—

Other disorders of glucose regulation and pancreatic internal secretion

4.22

4.81

1.3

1.2

—

Other symptoms and signs involving the digestive system and abdomen

2.83

4.80

1.0

1.1

—

Other abnormal uterine and vaginal bleeding

2.45

4.79

1.2

1.1

—

SLE (Finngen)

9.05

4.78

1.1

1.5

—

Diseases of oesophagus, stomach and duodenum

119

450

1.56

4.76

1.2

1.1

—

Pulmonary heart disease

163

2.21

4.76

1.1

1.2

—

Pulmonary embolism

163

2.21

4.76

1.1

1.2

—

Benign neoplasm of meninges

3.28

4.74

1.1

—

Other anxiety disorders

217

1.96

4.71

1.2

—

Renal failure

284

1.83

4.68

1.1

1.2

—

Chronic laryngitis and laryngotracheitis

2.84

4.64

1.4

1.1

—

Infections with a predominantly sexual mode of transmission

171

2.16

4.63

1.3

1.1

—

Speech and linguistic disorders

4.64

4.61

1.6

1.2

—

Diabetic nephropathy, excluding more controls

2.76

4.61

1.1

—

Other dialysis

6.16

4.61

1.1

1.3

—

Diseases of the ear and mastoid process

119

382

1.56

4.60

1.2

—

Persons encountering health services for specific procedures and health care

115

435

1.56

4.60

1.1

1.2

—

Other extrapyramidal and movement disorders in other diseases

134

2.32

4.57

1.2

—

Sub-endpoint used in defining T1D endpoints

163

2.18

4.57

1.1

—

Other disorders of ear

101

408

1.60

4.57

1.1

1.2

—

Other intervertebral disc disorders

329

1.65

4.57

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

255

1.82

4.56

1.2

1.1

—

Internal derangement of knee

224

1.99

4.55

1.2

1.1

—

Type 2 diabetes

108

396

1.58

4.53

1.1

1.2

—

Asthma, excluding more controls

182

1.83

4.52

1.2

1.1

—

Misadventures to patients during surgical and medical care

2.72

4.50

1.3

1.1

—

Anxiety (asthma-related co-morbidities)

272

1.79

4.49

1.2

1.1

—

Injuries to the ankle and foot

416

1.66

4.49

1.2

1.1

—

Diseases of the skin and subcutaneous tissue

104

326

1.60

4.48

1.2

1.1

—

Asthma

195

1.80

4.46

1.2

1.1

—

Bacterial, viral and other infectious agents

3.27

4.46

1.0

1.2

—

Unspecific neurodegenerative disorder

195

1.90

4.45

1.1

1.2

—

Genitourinary diseases

157

1.89

4.44

1.2

1.1

—

Polyuria

136

2.28

4.43

1.1

1.2

—

Sequelae of infectious and parasitic diseases

4.39

4.43

1.4

1.2

—

Bronchitis

119

466

1.53

4.42

1.1

1.2

—

Other female pelvic inflammatory diseases

2.62

4.38

1.3

1.1

—

Injury, poisoning and certain other consequences of external causes

147

1.91

4.38

1.1

1.2

—

Asthma, unspecified (mode), excluding more controls

176

1.95

4.34

1.3

1.1

—

Striking against or struck by other objects

203

2.02

4.33

1.1

—

Crohn's disease NAS

4.26

4.31

1.1

1.2

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

5.02

4.31

1.4

1.2

—

Dermatitis due to substances taken internally

5.02

4.31

1.3

—

Post-traumatic stress disorder

5.01

4.31

1.3

1.2

—

Neoplasms

256

1.68

4.31

1.1

—

Pain in throat and chest

323

1.63

4.30

1.2

1.1

—

Giant cell arteritis with polymyalgia rheumatica

6.29

4.29

1.6

1.3

—

Somnolence, stupor and coma

6.28

4.29

1.4

1.2

—

Paraplegia, diplegia of upper limbs

8.96

4.28

1.1

1.4

—

Papilloedema, unspecified

8.95

4.28

1.1

1.6

—

Leisure time condition

101

2.48

4.28

1.1

—

Inflammatory diseases of prostate (prostatitis)

2.78

4.27

1.2

—

Vitreous haemorrhage

2.96

4.27

1.1

1.2

—

All influenza (not pneumonia)

2.78

4.27

1.0

1.2

—

Dermatitis

419

1.68

4.26

1.2

1.1

—

Other and unspecified anaemias

277

1.83

4.25

1.1

1.2

—

Diseases of inner ear

374

1.71

4.25

1.1

—

Injuries to the thorax

311

1.80

4.23

1.1

—

Injuries to the knee and lower leg

131

475

1.49

4.22

1.2

1.1

—

Asthma (only as main-diagnosis), excluding more controls

182

1.82

4.20

1.2

1.1

—

Non-follicular lymphoma

3.15

4.20

1.1

1.2

—

Explicit bacterial Sepsis

3.42

4.18

1.1

1.2

—

Mental and behavioural disorders due to psychoactive substance use

380

1.69

4.17

1.2

1.1

—

Other anaemias

278

1.82

4.17

1.1

1.2

—

Acute generalized exanthematous pustulosis

5.26

4.14

1.3

—

Mood [affective] disorders

111

466

1.53

4.13

1.1

1.2

—

Temporal arteritis

5.91

4.13

1.6

1.2

—

Postprocedural disorders of nervous system

4.35

4.12

1.1

1.2

—

Deviated nasal septum

214

1.96

4.12

1.2

1.1

—

Open wound of wrist and hand

282

1.82

4.11

1.1

—

Mood disorders

111

466

1.52

4.10

1.1

1.2

—

Other specified/unspecified arthritis

154

2.15

4.10

1.1

1.2

—

Alcohol withdrawal state with delirium

4.02

4.09

1.3

1.2

—

Diabetic neuropathy

2.79

4.07

1.2

1.1

—

All anxiety disorders

287

1.73

4.07

1.2

1.1

—

Open wound of head

330

1.74

4.06

1.1

1.2

—

Substance abuse

375

1.69

4.05

1.2

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

4.63

4.05

1.1

1.2

—

Volume depletion

3.20

4.05

1.1

—

Dermatitis and eczema

122

484

1.49

4.04

1.2

1.1

—

severe traumatic brain injury, does not include concussion

129

2.25

4.04

1.0

1.2

—

Asthma (mode)

198

1.75

4.03

1.3

1.1

—

Other problems related to primary support group, including family circumstances

2.96

4.02

1.3

1.1

—

Caries of dentine

131

2.21

3.98

1.1

—

Generalized skin eruption due to drugs and medicaments

5.58

3.97

1.3

—

Asthma, unspecified (mode)

189

1.87

3.96

1.3

1.1

—

Crohn disease

2.60

3.96

1.1

1.2

—

Disorders of conjunctiva

450

1.57

3.96

1.2

1.1

—

Hypokalaemia

2.82

3.95

1.3

1.1

—

Other diseases of intestines

112

412

1.51

3.94

1.2

1.1

—

Anogenital herpesviral [herpes simplex] infection

4.46

3.93

1.6

1.1

—

Chronic apical periodontitis

121

456

1.49

3.93

1.1

—

Disorders of mineral metabolism

3.13

3.92

1.1

1.2

—

Undetermined asthma, excluding more controls

3.26

3.89

1.4

1.1

—

Suicide or other Intentional self-harm

138

2.18

3.88

1.1

—

Dialysis

4.81

3.87

1.0

1.2

—

Other arthritis (FG)

185

2.00

3.86

1.1

1.2

—

Irritable bowel syndrome

158

2.09

3.86

1.2

1.1

—

Dyspnoea

467

1.53

3.85

1.2

1.1

—

Bacterial, viral and other infectious agents, including avohilmo

2.97

3.84

1.0

1.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

289

1.78

3.84

1.2

1.1

—

Any dementia, excluding more controls

157

1.93

3.84

1.2

1.1

—

359

1.67

3.83

1.2

1.1

—

Systemic lupus erythematosus

6.03

3.82

1.1

1.4

—

Other CVD

107

2.34

3.81

1.1

1.2

—

Other specified/unspecified systemic involvement of connective tissue

4.30

3.81

1.5

1.3

—

Decubitus ulcer and pressure area

4.30

3.81

1.0

1.2

—

Other shoulder lesions

3.07

3.80

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

225

1.89

3.79

1.1

—

Monoplegia

8.84

3.78

1.7

1.5

—

Lagophthalmos

12.13

3.77

1.2

1.6

—

Explicit bacterial Sepsis, including avohilmo

3.19

3.77

1.1

1.2

—

Other renal tubulo-interstitial diseases

12.06

3.76

1.2

1.6

—

Depression

102

450

1.52

3.75

1.1

1.2

—

Sequelae of other and unspecified infectious and parasitic diseases

4.60

3.74

1.5

1.2

—

Nephropathy related operations

2.64

3.72

1.1

1.2

—

Dialysis, with operation codes

2.57

3.71

1.2

—

Colonic or urogenital fistula

154

2.08

3.71

1.2

—

Hypothyroidism and >3 levothyroxin purchases

2.97

3.71

1.2

1.0

—

Hypothyroidism, levothyroxine purchases

2.97

3.71

1.2

1.0

—

Tonsillectomy and adenotomy

222

1.76

3.70

1.1

—

Giant cell arteritis

5.02

3.69

1.6

1.2

—

Abnormal spermatozoa

2.79

3.68

1.2

—

Chronic sinusitis

259

1.81

3.68

1.3

1.1

—

Family history of certain disabilities and chronic diseases leading to disablement

5.64

3.66

1.2

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

189

1.96

3.65

1.1

1.2

—

Allergic contact dermatitis

2.69

3.65

1.1

1.2

—

Other infectious diseases, including avohilmo

3.12

3.64

1.2

—

Superficial injury of head

135

2.15

3.64

1.1

—

DVT of lower extremities and pulmonary embolism

267

1.79

3.61

1.1

1.2

—

Erysipelas, including avohilmo

341

1.61

3.60

1.1

—

Disorders of vestibular function (Vertigo)

312

1.72

3.58

1.1

—

Other/unspecified dorsalgia

209

1.89

3.57

1.1

—

Constipation

440

1.51

3.57

1.2

1.1

—

Fracture of skull and facial bones

117

2.23

3.56

1.1

—

Complications of genitourinary prosthetic devices, implants and grafts

7.82

3.56

1.0

1.6

—

Asthma (only as main-diagnosis)

195

1.72

3.55

1.2

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

389

1.51

3.53

1.1

—

Osteoporosis

150

2.02

3.52

1.1

—

Use of rivastigmine

2.50

3.51

1.1

1.2

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

5.32

3.51

1.1

1.2

—

Preparatory care for dialysis

4.25

3.50

1.2

—

SLE, ICD10

6.18

3.50

1.1

1.5

—

SLE, strict definition

6.18

3.50

1.1

1.5

—

Dyshidrosis [pompholyx]

10.08

3.50

1.2

1.8

—

Other diseases of blood and blood-forming organs, wide

131

2.14

3.50

1.4

1.2

—

Soft tissue disorders

104

355

1.50

3.49

1.1

1.2

—

Alcohol use disorder, Swedish definition

341

1.65

3.48

1.2

1.1

—

Conjunctivitis

407

1.56

3.47

1.2

1.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

208

1.85

3.46

1.3

1.1

—

Other blood glucose lowering drugs, excl. Insulins

2.54

3.45

1.3

1.2

—

Other nutritional deficiencies

415

1.58

3.43

1.2

1.1

—

Problems related to lifestyle

2.76

3.41

1.4

1.1

—

Erysipelas

292

1.68

3.41

1.1

—

Poisoning by medicine

126

2.15

3.40

1.0

1.1

—

Undetermined asthma

2.98

3.40

1.4

1.1

—

Cutaneous abscess, furuncle and carbuncle

153

2.03

3.39

1.3

1.1

—

Hypothyroidism, drug reimbursement

3.99

3.39

1.2

1.0

—

Schizophrenia or delusion, excluding more controls

151

2.03

3.38

1.0

1.1

—

Dental caries

144

2.03

3.37

1.1

—

Radiculopathy

2.44

3.37

1.1

1.2

—

Benign neoplasm of other and unspecified endocrine glands

2.50

3.37

1.2

—

Sicca syndrome [Sjögren]

3.10

3.37

1.2

—

Elevated blood glucose level

3.10

3.37

1.1

1.2

—

Other diseases of spinal cord

7.03

3.36

1.1

1.5

—

Hidradenitis suppurativa

7.02

3.36

1.1

1.4

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

2.84

3.35

1.5

1.1

—

Mental and behavioural disorders due to alcohol

333

1.66

3.35

1.2

1.1

—

370

1.60

3.34

1.2

1.1

—

Depression or dysthymia

194

1.69

3.33

1.1

—

Diseases of liver

210

1.86

3.33

1.2

—

Hypertension, essential

289

1.56

3.33

1.1

—

Acute renal failure

134

2.09

3.32

1.1

1.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

323

1.57

3.31

1.2

1.1

—

Triptan medication for migraine, single purchase ok

323

1.57

3.31

1.2

1.1

—

Dementia in other diseases classified elsewhere

4.36

3.31

1.0

1.3

—

Pain associated with micturition

2.62

3.29

1.1

1.2

—

Enterocolitis due to Clostridium difficile

2.62

3.29

1.0

1.2

—

FESS (DNB20)

2.54

3.29

1.3

1.1

—

Other Crohn's disease

3.65

3.29

1.0

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

105

426

1.47

3.29

1.1

—

Allergic asthma (mode), excluding more controls

2.47

3.28

1.1

—

Candidiasis, including avohilmo

183

1.91

3.27

1.1

—

Obstructive hydrocephalus

8.64

3.27

1.2

1.6

—

Myasthenia gravis

8.64

3.27

1.2

1.6

—

117

411

1.44

3.26

1.2

1.1

—

Other disorders of bladder

2.78

3.25

1.1

—

Pure hypercholesterolaemia

319

1.55

3.23

1.2

1.1

—

L04AD Calcineurin inhibitors

2.67

3.22

1.2

—

Other disorders of nervous system

3.34

3.22

1.2

—

Streptococcal septicaemia

3.34

3.22

1.2

1.3

—

Streptococcal septicaemia, including avohilmo

3.34

3.22

1.2

1.3

—

Cardiac arrhythmias

208

1.70

3.22

1.1

—

Hypothyroidism (congenital or acquired)

2.80

3.21

1.1

1.0

—

Benign neoplasm: Cerebral meninges

2.86

3.19

1.0

1.2

—

Myositis

6.40

3.19

1.0

1.3

—

Covid-19 suspected case

123

2.12

3.19

1.0

1.1

—

Chorioretinal inflammation

6.39

3.19

1.0

1.4

—

Systemic lupus erythematosus, unspecified

6.39

3.19

1.1

1.5

—

Kidney transplant status

3.81

3.18

1.1

1.2

—

Focal brain injury

6.37

3.18

1.0

—

Implicit fungal Sepsis, including avohilmo

3.80

3.18

1.1

1.2

—

Osteoporosis with pathological fracture (FG)

3.80

3.18

1.1

—

Fracture of rib(s), sternum and thoracic spine

207

1.84

3.15

1.0

1.2

—

Cough

241

1.74

3.11

1.3

1.1

—

Unspecified dementia

2.86

3.11

1.1

1.2

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.29

3.09

1.0

1.1

—

Trigeminal neuralgia

3.68

3.08

1.0

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.68

3.08

1.0

1.2

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.68

3.08

1.0

1.2

—

Hernia of abdominal wall, postoperative

2.61

3.08

1.1

—

Disorders of sclera, cornea, iris and ciliary body

375

1.60

3.06

1.2

1.1

—

Other and unspecified hydrocephalus

7.55

3.06

1.2

1.5

—

Other diseases of the digestive system

202

1.83

3.05

1.1

—

Diabetic nephropathy

104

2.19

3.05

1.1

—

Fungal Sepsis

5.02

3.05

1.0

1.2

—

Other heart diseases, wide

391

1.47

3.05

1.1

1.2

—

Sacroiliitis, not elsewhere classified

5.01

3.05

1.1

1.4

—

Hypertension

295

1.53

3.05

1.1

—

Diabetic maculopathy

2.51

3.02

1.1

—

Other infectious diseases

3.34

3.01

1.3

1.2

—

Hypertensive diseases

296

1.52

3.01

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

196

1.84

3.00

1.3

1.1

—

Unspecified misadventure during surgical and medical care

3.56

2.99

1.3

—

Crohn disease (strict definition, require KELA)

3.56

2.99

1.0

1.2

—

Hypopituitarism

3.56

2.98

1.2

—

Other bacterial agents as the cause of diseases classified to other chapters

10.10

2.98

1.0

1.6

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

10.08

2.98

1.0

1.6

—

Personal history of certain other diseases

10.05

2.98

1.8

1.0

—

Unspecified haematuria

218

1.72

2.98

1.1

1.2

—

Secondary parkinsonism, excluding more controls

10.04

2.98

1.0

—

Allergic asthma (mode)

2.35

2.96

1.1

—

KRA_PSY_EATING, excluding more controls

4.25

2.96

1.0

1.2

—

Acute upper respiratory infections

107

449

1.43

2.96

1.2

1.1

—

Ethmoidectomy

2.40

2.96

1.3

1.1

—

Hypotension

2.24

2.95

1.1

1.2

—

Dental operations

189

1.63

2.95

1.2

1.1

—

Exposure to other and unspecified inanimate mechanical forces

3.25

2.93

1.1

1.2

—

Disorder of external ear, unspecified

4.73

2.92

1.1

1.4

—

Chronic diseases of tonsils and adenoids

325

1.51

2.92

1.2

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

6.13

2.91

1.0

1.1

—

Diabetic retinopathy

142

1.79

2.91

1.1

—

Mycoses, including avohilmo

514

1.44

2.90

1.2

1.1

—

Benign neoplasm of brain and other parts of central nervous system

3.45

2.89

1.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

302

1.58

2.89

1.1

1.2

—

Pain in thoracic spine

2.37

2.88

1.2

—

Seronegative rheumatoid arthritis

2.70

2.88

1.0

1.2

—

Polymyalgia rheumatica

2.43

2.87

1.3

1.2

—

Carrier of infectious disease

6.70

2.87

1.2

1.6

—

Injuries to the wrist and hand

106

497

1.41

2.84

1.2

1.1

—

Benign neoplasms

374

1.44

2.83

1.2

1.1

—

Bipolar affective disorders

2.19

2.82

1.1

—

Other cataract

213

1.68

2.81

1.2

—

Extracorporeal dialysis

3.34

2.81

1.1

1.2

—

Tuberculosis, IBD comorbidity

3.34

2.81

1.5

1.2

—

Tuberculosis, wide

3.34

2.81

1.5

1.2

—

Tuberculosis, wide, including avohilmo

3.34

2.81

1.5

1.2

—

Unspecified/other endometriosis

2.77

2.80

1.1

—

Other peripheral vertigo

2.65

2.79

1.1

1.2

—

Disorders of muscles

2.65

2.79

1.0

1.2

—

Tobacco use

3.58

2.78

1.5

1.2

—

COPD (mode)

127

1.90

2.78

1.3

1.1

—

Crohn disease (strict definition, all UC cases excluded)

3.92

2.77

1.0

1.3

—

Diseases of tongue

3.92

2.77

1.1

1.2

—

Cerebral aneurysm, nonruptured

3.08

2.77

1.2

—

Other specified/unspecified necrotizing vasculopathies

8.40

2.75

1.2

1.3

—

Vertigo of central origin

8.39

2.75

1.0

1.5

—

Undefined dementia

2.64

2.73

1.1

1.2

—

Implicit fungal Sepsis

5.02

2.73

1.0

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

3.24

2.72

1.0

1.2

—

Reactive arthropathies, FINNGEN

3.24

2.72

1.0

1.2

—

Other sleep disorders

2.71

1.1

—

Substance use, excluding alcohol

118

2.04

2.70

1.2

1.1

—

Other bacterial intestinal infections

2.15

2.70

1.1

1.2

—

Alcohol use disorder, ICD-based

271

1.66

2.70

1.2

—

Early onset COPD

125

2.00

2.69

1.4

1.2

—

Fissure and fistula of anal and rectal regions

139

1.94

2.69

1.1

1.2

—

Hepatic failure, not elsewhere classified

4.23

2.68

1.4

1.3

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

3.76

2.67

1.2

1.3

—

Other enthesopathies

175

1.83

2.66

1.2

1.1

—

Injuries to the shoulder and upper arm

492

1.43

2.66

1.2

1.1

—

Fall on and from stairs and steps

161

1.87

2.65

1.1

1.2

—

Alzheimer’s disease (Early onset), excluding more controls

7.87

2.64

1.2

1.0

—

Any dementia

186

1.67

2.61

1.2

1.1

—

Diseases of peritoneum

2.46

2.61

1.0

1.2

—

Carpal tunnel syndrome

351

1.53

2.61

1.2

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

300

1.50

2.60

1.2

1.1

—

Lymphoid leukaemia

3.34

2.60

1.1

1.3

—

Chondrocostal junction syndrome [Tietze]

4.68

2.60

1.0

1.4

—

Poisoning by drugs, medicaments and biological substances

141

1.92

2.59

1.0

1.1

—

Rheumatoid arthritis

162

1.80

2.59

1.1

1.2

—

Spondylopathies

308

1.48

2.59

1.2

1.1

—

Bacterial intestinal infections, IBD co-morbidities

100

2.10

2.58

1.1

1.2

—

Crohn's disease of large intestine

3.61

2.57

1.1

1.2

—

Monoarthritis, not elsewhere classified

4.01

2.57

1.3

1.2

—

Disorders of calcium metabolism

3.06

2.56

1.1

1.2

—

Crohn's disease of small intestine

3.06

2.56

1.0

1.3

—

Benign neoplasm: Brain, supratentorial

7.19

2.55

1.0

1.6

—

Drug-induced osteoporosis with pathological fracture

7.19

2.55

1.2

1.3

—

Deficiency of other B group vitamins

7.18

2.55

1.0

1.6

—

Superficial injury of lower leg

149

1.88

2.55

1.2

1.1

—

Use of donepezil

102

2.06

2.54

1.1

—

Other intracranial haemorrhages

5.47

2.54

1.2

1.4

—

6-mercaptopurine

5.47

2.54

1.0

1.5

—

Urticaria and erythema

230

1.70

2.54

1.2

1.1

—

Non-selective monoamine reuptake inhibitors

192

1.75

2.52

1.2

—

Other and unspecified mood [affective] disorders

3.23

2.51

1.2

—

GI-bleeding

201

1.74

2.50

1.1

—

Other disorders of kidney and ureter

2.27

2.50

1.1

1.2

—

Other bacterial intestinal infections, including avohilmo

129

1.94

2.49

1.1

1.2

—

Chronic gastritis

165

1.82

2.48

1.2

—

Other diseases of upper respiratory tract

107

403

1.38

2.47

1.2

1.1

—

Nonorganic sleeping disorders, excluding more controls

102

2.06

2.46

1.0

1.1

—

Other disorders of bone

109

2.02

2.45

1.1

—

Reactive arthropathies

2.67

2.45

1.1

1.2

—

Vocal cord dysfunction

2.71

2.45

1.2

1.1

—

Reimbursement for rheumatic diseases

379

1.52

2.44

1.2

1.1

—

Other and unspecified visual disturbances

2.46

2.44

1.1

—

Use of levodopa decarboxylase inhibitor

2.24

2.43

1.1

1.2

—

Other disorders of penis

2.55

2.43

1.2

—

Other/unspecified reactive arthropathies

3.13

2.43

1.0

1.3

—

Urticaria

181

1.77

2.42

1.2

1.1

—

Other (seronegative) rheumatoid arthritis, wide

103

2.04

2.41

1.0

1.1

—

Amyloidosis

5.03

2.40

1.2

1.3

—

Parkinson's disease

2.17

2.40

1.1

1.2

—

Ectropion of eyelid

5.01

2.40

1.2

1.1

—

Cardiac arrest

3.15

2.40

1.0

1.1

—

Other and unspecified effects of external causes

167

1.80

2.39

1.1

—

Calculus of lower urinary tract

3.34

2.39

1.0

1.2

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.33

2.38

1.1

1.2

—

Optic atrophy

6.29

2.37

1.2

1.5

—

Optic atrophy, wide definition

6.28

2.37

1.2

1.5

—

Communicating hydrocephalus

6.28

2.37

1.0

1.3

—

Patent foramen ovale

6.28

2.37

1.2

1.5

—

Tuberculosis of other organs, strict

6.28

2.37

1.0

1.3

—

Tuberculosis of other organs, strict, including avohilmo

6.28

2.37

1.0

1.3

—

Other facial nerve disorders

6.27

2.37

1.0

1.5

—

Heart failure and antihypertensive medication

1.96

2.37

1.0

1.1

—

Non-Hodgkin lymphoma, all

3.65

2.36

1.3

—

Convergent concomitant strabismus

3.64

2.36

1.1

1.2

—

Varicella [chickenpox], including avohilmo

3.64

2.36

1.1

1.2

—

Complications of other internal prosthetic devices, implants and grafts

4.13

2.36

1.4

—

Obsessive-compulsive disorder

4.12

2.36

1.3

1.2

—

Embolic stroke

4.12

2.36

1.0

1.3

—

Smoking dependency

2.51

2.35

1.3

1.2

—

Mental and behavioural disorders due to tobacco

2.51

2.35

1.3

1.2

—

Coxibs

1.91

2.35

1.2

1.1

—

Gout, strict definition

111

1.98

2.35

1.1

1.2

—

Other disorders of eyelid

288

1.57

2.34

1.2

1.1

—

Other (not insulin) diabetes medications

401

1.39

2.34

1.1

—

Sarcoidosis

2.26

2.34

1.3

1.1

—

Venous thromboembolism

364

1.51

2.32

1.1

1.2

—

Biguanides

424

1.38

2.31

1.1

1.2

—

Asthma and allergy, excluding more controls

2.79

2.30

1.1

—

5-aminosalicylic acid

105

2.00

2.30

1.1

—

Enthesopathies of lower limb, excluding foot

126

1.91

2.30

1.2

—

Use of hypnotics and sedatives

109

460

1.35

2.28

1.1

1.2

—

Degenerative diseases of the nervous system

174

1.65

2.28

1.2

1.1

—

Acute peritonitis

2.95

2.28

1.0

1.2

—

Other follicular disorders

2.95

2.28

1.3

1.2

—

Brain meningioma, including Hilmo

3.49

2.27

1.0

1.3

—

Ocular pain

2.56

2.27

1.3

1.2

—

Inflammatory bowel disease, strict (require KELA)

141

1.85

2.26

1.1

—

Septal defects

3.15

2.25

1.2

1.3

—

Conjunctivitis (acute, non atopic), including avohilmo

101

447

1.36

2.24

1.1

—

Haemangioma and lymphangioma, any site

0.00

2.24

0.0

1.2

—

Parkinson's disease, strict definition

2.15

2.24

1.1

1.2

—

Impingement syndrome of shoulder

149

1.81

2.23

1.3

1.2

—

Sequelae of external causes of morbidity and mortality

149

1.81

2.23

1.1

—

Shoulder lesions

313

1.44

2.23

1.1

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

104

406

1.36

2.23

1.1

—

Congenital malformations of cardiac septa

3.12

2.22

1.2

1.3

—

Parkinson's disease, including avohilmo

2.10

2.22

1.1

1.2

—

Superficial injury of hip and thigh

2.09

2.22

1.1

—

Retinoschisis and retinal cysts

5.58

2.21

1.0

1.3

—

Cytomegaloviral disease

5.58

2.21

1.6

1.4

—

Cytomegaloviral disease, including avohilmo

5.58

2.21

1.6

1.4

—

Autonomic disorders

5.58

2.21

1.4

1.7

—

Inflammatory bowel disease

194

1.70

2.21

1.1

—

Diseases of the digestive system

308

1.55

2.21

1.1

1.2

—

Abnormal findings on diagnostic imaging of other body structures

2.19

2.20

1.1

1.2

—

Follow-up examination after treatment for malignant neoplasms

2.69

2.20

1.0

1.1

—

Other and unspecified urticaria

107

1.96

2.19

1.3

1.1

—

Candidiasis

2.13

2.18

1.1

—

Special screening examination for neoplasms

3.34

2.18

1.1

1.2

—

Other obstetric conditions, not elsewhere classified

1.82

2.17

1.2

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

335

1.42

2.16

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

369

1.47

2.16

1.2

1.1

—

Erosion and ectropion of cervix uteri

4.30

2.15

1.3

1.1

—

Chronic hepatitis, not elsewhere classified

4.30

2.15

1.2

1.3

—

Adrenocortical insufficiency

4.30

2.15

1.2

1.4

—

Obesity due to excess calories

313

1.53

2.15

1.2

—

Neuralgia and neuritis, unspecified

3.01

2.14

1.2

—

Methotrexate

2.30

2.14

1.6

1.2

—

Other symptoms and signs involving the circulatory and respiratory systems

2.62

2.14

1.4

1.1

—

Diseases of oral cavity, salivary glands and jaws

190

1.52

2.13

1.1

—

Noninfective enteritis and colitis

305

1.54

2.13

1.1

1.2

—

Hyperlipidaemia, other/unspecified

238

1.59

2.13

1.2

—

Other and unspecified injuries of head

2.78

2.13

1.2

1.1

—

Gout, unspecified

130

1.85

2.11

1.1

1.2

—

Keratitis

220

1.64

2.11

1.3

1.2

—

Panic disorder

2.21

2.10

1.1

—

IBD patients in KELA-register

145

1.79

2.09

1.1

—

Rheumatoid arthritis, including avohilmo

236

1.61

2.09

1.1

—

Somatoform disorder

2.14

2.08

1.1

—

Disorders of parathyroid gland

108

1.92

2.08

1.0

1.1

—

Agranulocytosis

2.26

2.07

1.2

—

Viral pneumonia

2.26

2.07

1.1

1.2

—

Viral and other specified intestinal infections, including avohilmo

147

1.77

2.07

1.1

—

Use of galantamine

2.71

2.07

1.0

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

390

1.43

2.06

1.2

—

Varicella [chickenpox]

3.51

2.05

1.1

1.3

—

Other and unspecified nonorganic psychotic disorders

117

1.88

2.05

1.0

1.1

—

Schizophrenia, schizotypal and delusional disorders

191

1.68

2.05

1.1

—

Familial hypercholesterolemia

2.03

2.05

1.3

1.2

—

Functional dyspepsia

176

1.71

2.05

1.0

1.1

—

Amputation

2.32

2.04

1.1

1.2

—

Spinal instabilities

4.02

2.04

1.0

1.4

—

Fentanyl

2.40

2.01

1.0

1.2

—

Cluster headache, strict, including avohilmo

3.08

2.01

1.1

1.3

—

Cluster headache, wide,, including avohilmo

3.08

2.01

1.1

1.3

—

Intermittent heterotropia

3.08

2.01

1.1

1.2

—

Assault by bodily force

2.64

2.00

1.1

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.79

2.00

1.2

1.1

—

Tongue abnormality

2.82

2.00

1.1

1.3

—

Gout

145

1.72

1.99

1.1

1.2

—

Acute and transient psychotic disorders

2.15

1.98

1.1

—

Other and unspecified disorders of white blood cells

3.34

1.96

1.1

1.3

—

Systemic atrophies primarily affecting the central nervous system

3.34

1.96

1.3

—

Endometriosis of ovary

2.00

1.96

1.1

—

Migraine with aura and triptan purchases

1.98

1.94

1.2

1.1

—

Cytomegalovirus infection, IBD co-morbidity

4.56

1.94

1.6

1.5

—

Exposure to other and unspecified animate mechanical forces

4.56

1.94

1.0

1.5

—

Malignant neoplasm of breast, ER-positive, including Hilmo

137

1.68

1.94

1.0

1.2

—

Other and unspecified psoriasis

2.57

1.94

1.2

—

Foreign body entering into or through eye or natural orifice

2.57

1.94

1.1

1.2

—

Chronic conjunctivitis

3.76

1.93

1.7

1.4

—

Hyperkalaemia

2.73

1.93

1.0

1.2

—

Maternal care for other conditions predominantly related to pregnancy

1.93

1.91

1.2

1.1

—

Biological medication for rheuma

106

1.89

1.90

1.3

1.1

—

Disorders of skin appendages

329

1.48

1.90

1.2

1.1

—

Endometriosis

111

1.68

1.89

1.1

—

Benign neoplasm: Colon

372

1.44

1.89

1.2

—

Desensitization to allergens

3.19

1.88

1.4

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.93

1.87

1.1

1.2

—

Social phobias

2.86

1.86

1.4

1.2

—

Symptoms and signs concerning food and fluid intake

2.64

1.86

1.0

1.2

—

DVT of lower extremities

107

1.87

1.85

1.2

—

conjunctival haemorrhage

2.40

1.85

1.0

1.2

—

Other diseases of pleura

274

1.49

1.85

1.3

1.2

—

Haemangioma, any site

0.00

1.85

0.0

1.2

—

Arthropathies in other diseases classified elsewhere

3.54

1.84

1.0

1.2

—

Spondylopathies (FG)

2.21

1.84

1.2

1.1

—

Other disorders of male genital organs

3.54

1.84

1.2

—

Asthma and allergy

2.53

1.83

1.1

—

Immunodeficiency with predominantly antibody defects

4.18

1.82

1.6

1.5

—

Chondromalacia

4.18

1.82

1.4

1.5

—

Inguinal hernia, unilateral

4.18

1.82

1.0

1.4

—

Inguinal of femoral hernia, unilateral

4.18

1.82

1.0

1.4

—

Femoral hernia, unilateral

4.18

1.82

1.0

1.4

—

Other and unspecified mononeuropathies, also in other diseases

4.18

1.82

1.4

—

Other and unspecified intracranial injuries

4.18

1.82

1.0

1.2

—

Iridocyclitis

130

1.77

1.81

1.3

1.2

—

Retinal detachments and breaks

230

1.57

1.80

1.1

1.2

—

Subarachnoid haemorrhage

2.27

1.80

1.0

1.2

—

Acute pharyngitis

2.01

1.80

1.0

1.1

—

Schizophrenia or delusion

191

1.62

1.80

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

161

1.67

1.80

1.1

—

Brain meningioma

3.05

1.80

1.0

1.3

—

Respiratory tuberculosis

3.05

1.80

1.0

1.3

—

Respiratory tuberculosis, confirmed and not-confirmed

3.05

1.80

1.0

1.3

—

Other disorders of white blood cells

2.76

1.79

1.4

1.2

—

Sequelae of injuries of head

2.76

1.79

1.0

1.2

—

Tuberculosis

2.76

1.79

1.0

1.2

—

Obesity and other hyperalimentation

409

1.40

1.78

1.2

1.1

—

Combinations of oral blood glucose lowering drugs

184

1.63

1.77

1.2

—

Benign neoplasm of eye and adnexa

2.17

1.77

1.1

1.2

—

Personality disorders, excluding more controls

116

1.81

1.76

1.0

1.1

—

Urolithiasis

200

1.60

1.76

1.1

1.2

—

Angina pectoris

292

0.61

1.76

1.2

1.1

—

Chondropathies

1.90

1.75

1.1

—

Sequelae of injuries of neck and trunk

3.34

1.75

1.0

1.3

—

Hypogonadotropic hypogonadism

3.34

1.75

1.0

1.3

—

Other disorders of adrenal gland

3.34

1.74

1.2

1.3

—

Paroxysmal tachycardia

1.85

1.74

1.4

1.1

—

Burns and corrosions

1.98

1.74

1.1

1.2

—

Other otitis externa (chronic)

2.50

1.74

1.1

1.2

—

Invasive ventilation

2.50

1.74

1.0

1.2

—

Convalescence

2.67

1.72

1.0

1.2

—

Disorders resulting from impaired renal tubular function

2.93

1.72

1.0

1.3

—

Disorders of vitreous body and globe

351

1.43

1.72

1.1

1.2

—

Drug-induced cataract

3.86

1.71

1.2

1.4

—

Secondary parkinsonism

3.86

1.71

1.0

1.3

—

Secondary parkinsonism+Parkinsonism in other disease

3.86

1.71

1.0

1.2

—

Cluster headache, strict

3.85

1.71

1.2

—

Cluster headache, wide

3.85

1.71

1.2

—

Dissociative [conversion] disorders

3.85

1.71

1.0

1.3

—

Infective dermatitis

2.13

1.71

1.0

1.2

—

Other and unspecified dermatitis

364

1.43

1.71

1.2

1.1

—

Gout, idiopatic and unspecified

163

1.66

1.70

1.1

1.2

—

Malignant neoplasm of breast, HER-positive

137

1.63

1.70

1.0

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

262

1.51

1.70

1.0

1.1

—

Solid cancers

334

1.35

1.69

1.1

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1.95

1.69

1.1

1.2

—

Hyperfunction of pituitary gland

3.16

1.66

2.2

1.3

—

Type 2 diabetes, definitions combined

388

1.32

1.65

1.1

1.2

—

Immunodeficiencies

2.81

1.65

1.4

1.3

—

Benign neoplasm: Colon, unspecified

157

1.66

1.65

1.3

1.2

—

Postpartum care and examination

2.05

1.64

1.1

—

Disorders of vitreous body

349

1.42

1.64

1.1

1.2

—

Deep endometriosis

2.25

1.63

1.1

—

Obesity

409

1.38

1.63

1.2

1.1

—

Other strabismus

112

1.78

1.62

1.3

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

382

1.32

1.62

1.1

—

Other and unspecified injuries of shoulder and upper arm

3.58

1.61

1.2

1.4

—

Type 2 diabetes, strict (exclude DM1)

390

1.31

1.61

1.1

1.2

—

Vascular dementia

2.35

1.60

1.5

1.2

—

Endometriosis ASRM stages 3,4

128

1.72

1.59

1.1

—

Viral pneumonia (unknown virus, not influenza)

2.50

1.59

1.1

1.2

—

Other disorders of conjunctiva

1.91

1.59

1.1

1.2

—

Hyperkinetic disorders, excluding more controls

2.33

1.58

1.1

1.2

—

Right bundle-branch block

3.01

1.58

1.3

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

3.01

1.58

1.3

1.4

—

Other noninflammatory disorders of uterus, except cervix

1.80

1.58

1.3

1.1

—

Residual foreign body in soft tissue

2.70

1.58

1.1

1.3

—

Anorexia (incl.atypical)

3.00

1.58

1.0

1.2

—

Tumor necrosis factor alpha inhibitors

1.85

1.55

1.0

1.1

—

Otalgia

2.28

1.55

1.1

1.2

—

Chronic periodontitis, complicated

395

1.38

1.55

1.1

1.2

—

Other diseases of liver

107

1.78

1.54

1.1

—

Other/unspecified rheumatoid arthritis

2.03

1.54

1.1

—

Lesion of plantar nerve

2.43

1.53

1.1

1.2

—

Acute suppurative otitis media

142

1.64

1.53

1.1

—

Gout, FINNGEN

183

1.58

1.52

1.1

1.2

—

Other and unspecified injuries of ankle and foot

3.34

1.52

1.4

1.3

—

Viral and other specified intestinal infections

112

1.74

1.52

1.1

—

Other disorders of amniotic fluid and membranes

2.03

1.51

1.2

1.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

1.51

0.0

1.1

—

Noise effects on inner ear

2.86

1.50

1.5

1.2

—

All dysplastic lesions of the vulva

2.86

1.50

1.0

1.3

—

Contusion of other and unspecified parts of foot

2.86

1.50

1.3

1.2

—

Diseases of arteries, arterioles and capillaries

360

1.34

1.49

1.1

1.2

—

Restless leg syndrome

1.90

1.49

1.2

1.1

—

Thyroiditis, ILD-related definition

2.07

1.49

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.74

1.48

1.2

1.1

—

Gastric ulcer

101

1.78

1.48

1.2

—

Malignant neoplasm, including Hilmo

345

1.32

1.48

1.1

1.2

—

Pollen allergy

107

1.75

1.47

1.1

—

Malignant neoplasm, wide definition

345

1.32

1.47

1.1

1.2

—

Sulfonylureas

172

1.52

1.47

1.1

1.2

—

Vasomotor and allergic rhinitis

213

1.51

1.47

1.2

1.1

—

Excessive attrition of teeth

414

1.36

1.47

1.1

1.2

—

Hyperparathyroidism

1.81

1.46

1.0

1.2

—

Atopic dermatitis

298

1.39

1.46

1.2

1.1

—

Gingivitis and periodontal diseases

378

1.28

1.46

1.1

—

Hypercalcemia

2.51

1.45

1.1

1.3

—

Other ulcerative colitis

2.50

1.45

1.4

1.3

—

Thyrotoxicosis, other and/or unspecified

117

1.71

1.44

1.2

1.1

—

Superficial injury of wrist and hand

117

1.71

1.44

1.3

1.1

—

Familial hypercholesterolemia, with ischemic heart disease

2.12

1.44

1.5

1.2

—

Small fibre neuropathy

3.13

1.44

1.0

1.3

—

Optic neuritis

3.13

1.44

1.2

1.3

—

Other and unspecified abdominal hernia

2.73

1.43

1.0

1.3

—

Separation of retinal layers (serosa)

2.73

1.43

1.2

—

Ptosis of eyelid

2.04

1.43

1.3

1.1

—

Vulvovaginal ulceration/inflammation in other diseases

2.31

1.43

1.2

—

Disorders of the thyroid gland

439

1.28

1.42

1.1

1.2

—

Menorrhagia

107

1.56

1.41

1.2

1.1

—

Corneal ulcer

103

1.75

1.40

1.3

1.2

—

Eustachian salpingitis and obstruction

2.25

1.40

1.0

1.2

—

Neuromuscular dysfunction of bladder

2.25

1.40

1.1

—

Eating disorder

2.25

1.39

1.0

1.2

—

Benign paroxysmal vertigo

173

1.56

1.39

1.0

1.1

—

Assault

1.89

1.38

1.4

1.1

—

Other skin changes

111

1.71

1.38

1.3

1.2

—

Tinnitus

134

1.64

1.38

1.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.77

1.38

1.1

—

Dentofacial anomalies [including malocclusion]

363

1.34

1.38

1.2

1.1

—

Pruritus

2.00

1.38

1.0

1.2

—

Acetic acid derivatives and related substances

1.65

1.37

1.1

—

Hypermobility syndrome

2.61

1.36

1.0

1.2

—

Glucosamine medication

249

1.41

1.36

1.1

1.2

—

Benign neoplasm: Conjunctiva

2.95

1.36

1.0

1.4

—

Benign neoplasm: Skin of ear and external auricular canal

2.95

1.36

1.6

1.4

—

Otitis externa

135

1.63

1.35

1.1

—

Malignant neoplasm of colon, including Hilmo

104

1.72

1.34

1.1

1.2

—

Superficial injury of abdomen, lower back and pelvis

1.75

1.34

1.0

1.2

—

Thyrotoxicosis

151

1.59

1.34

1.2

1.1

—

Deforming dorsopathies

151

1.59

1.34

1.1

—

Peripheral artery operations in Hilmo

1.87

1.34

1.1

1.2

—

296

1.41

1.33

1.2

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

334

1.38

1.33

1.2

1.1

—

Lateral epicondylitis

1.91

1.33

1.1

—

Nonorganic sleeping disorders

128

1.64

1.32

1.0

1.1

—

Acute pancreatitis

105

1.72

1.32

1.3

1.2

—

Spondyloarthritis

1.78

1.32

1.2

—

Diseases of pulp and periapical tissues and dental caries

224

1.35

1.32

1.2

1.1

—

Ischemic heart diseases

365

1.29

1.32

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

403

1.26

1.32

1.2

1.1

—

Other fall from one level to another

136

1.62

1.31

1.2

1.1

—

Hypothyroidism, strict autoimmune

289

1.34

1.31

1.2

—

Insomnia

447

1.28

1.31

1.2

1.1

—

Episcleritis

2.50

1.30

1.2

1.3

—

Foreign body in alimentary tract

2.50

1.30

1.2

1.3

—

Sequelae with surgical and medical care as external cause

121

1.65

1.30

1.2

—

Postpartum haemorrhage

1.67

1.30

1.1

—

Temporomandibular joint disorders, including avohilmo

274

1.41

1.30

1.2

1.1

—

Special screening examination for other diseases and disorders

2.09

1.30

1.0

1.1

—

Myocardial infarction, without ST-elevation

255

1.42

1.30

1.2

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

140

1.59

1.29

1.0

1.2

—

Acne, including avohilmo

1.69

1.29

1.2

1.1

—

Abnormal findings on antenatal screening of mother

2.36

1.29

1.1

1.2

—

Solid cancers, including Hilmo

338

1.29

1.1

1.2

—

Endocarditis

2.78

1.28

1.0

1.3

—

Other noninflammatory disorders of cervix uteri

2.78

1.28

1.4

1.1

—

Polyhydramnios

2.78

1.28

1.4

1.1

—

Alzheimer’s disease (Early onset)

2.78

1.28

1.2

—

Unknown and unspecified causes of morbidity

2.78

1.28

1.2

—

Malignant neoplasm

340

1.29

1.28

1.1

1.2

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

177

1.53

1.28

1.1

—

Diseases of middle ear and mastoid

307

1.36

1.28

1.1

—

Adverse effects, not elsewhere classified

114

1.67

1.27

1.1

—

Left bundle-branch block

2.09

1.27

1.1

1.2

—

Other superficial mycoses, including avohilmo

1.94

1.27

1.5

1.2

—

Eating disorders

2.08

1.27

1.0

1.2

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.69

1.27

1.1

1.2

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.72

1.26

1.2

1.1

—

Drug-induced neutropenia

2.05

1.26

1.0

1.2

—

Cyst of kidney

2.05

1.26

1.1

1.2

—

Acne vulgaris

2.28

1.26

1.1

1.2

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

159

1.45

1.26

1.0

1.2

—

Malignant neoplasm of breast, including Hilmo

159

1.45

1.26

1.0

1.2

—

Phobic anxiety disorders

2.00

1.26

1.3

1.1

—

Hernia

459

1.26

1.25

1.1

1.2

—

Purpura and other haemorrhagic conditions

1.82

1.25

1.1

—

Chronic ulcer of skin, not elsewhere classified

2.23

1.24

1.1

1.2

—

Basal cell carcinoma

199

1.40

1.23

1.2

—

Alcohol abuse, main dg, excluding more controls

1.86

1.23

1.0

1.1

—

Use of disulfiram, acamprosate or naltrexone

2.00

1.23

1.1

1.2

—

Other/unspecified enthesopathies, not elsewhere classified

2.00

1.23

1.4

1.2

—

Spontaneous rupture of synovium and tendon

2.00

1.23

1.3

1.2

—

Acute alcohol intoxication

155

1.55

1.22

1.1

1.2

—

Injuries to the hip and thigh

310

1.36

1.22

1.1

—

Non-invasive ventilation

1.71

1.22

1.5

1.1

—

Non-small cell lung cancer, squamous, helper endpoint

2.64

1.21

1.2

—

Other diseases of stomach and duodenum

2.17

1.21

1.5

1.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

116

1.64

1.21

1.0

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

188

1.49

1.20

1.4

1.1

—

Suppurative and unspecified otitis media

195

1.45

1.20

1.1

—

Postpartum hemorraghe, parous women as controls

103

1.62

1.20

1.1

—

Nonsuppurative otitis media

107

1.62

1.20

1.0

1.2

—

Secondary uncertain malignant neoplasm

1.83

1.19

1.1

1.2

—

Malignant neoplasm

339

1.28

1.19

1.1

1.2

—

Malignant neoplasm of breast

157

1.44

1.19

1.0

1.2

—

Sleep disorders

449

1.26

1.19

1.2

1.1

—

Abnormal findings on examination of blood, without diagnosis

307

1.36

1.18

1.1

1.2

—

Retained placenta and membranes, without haemorrhage

1.88

1.18

1.0

1.1

—

Anterior Iridocyclitis

117

1.63

1.17

1.2

1.1

—

Sudden idiopathic hearing loss

1.93

1.17

1.1

1.2

—

Achilles tendinitis

1.93

1.17

1.3

1.2

—

Sulfasalazine

157

1.53

1.17

1.1

—

Non-ischemic cardiomyopathy

182

1.44

1.16

1.1

1.2

—

Lumbar disc prolapse

315

1.32

1.16

1.0

1.2

—

Glomerulonephritis

2.00

1.16

1.0

1.2

—

Open wound of ankle and foot

2.00

1.16

1.5

1.2

—

Other specified/unspecified dorsopathies

2.50

1.15

1.0

1.3

—

Malignant neoplasm of mesothelium and soft tissue

2.50

1.15

1.0

1.4

—

Toxic effect of contact with venomous animals

2.50

1.15

1.0

1.4

—

Olecranon bursitis

0.00

1.15

0.0

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

110

1.64

1.15

1.2

1.1

—

Retinal detachment with retinal break

1.81

1.15

1.2

—

Otitis externa, unspecified

1.81

1.15

1.0

1.2

—

Nonsuppurative otitis media, including avohilmo

157

1.49

1.14

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

126

1.59

1.14

1.2

—

Dental caries, including avohilmo

257

1.29

1.13

1.1

—

Cholecystectomy

431

1.28

1.13

1.1

1.2

—

Statin medication

249

1.31

1.13

1.1

—

Appendectomy

409

1.30

1.13

1.1

1.2

—

Irregular menses

205

1.39

1.13

1.2

1.1

—

Cirrhosis of liver, NAS

2.34

1.12

1.0

1.2

—

Other or ill-defined heart diseases

2.34

1.12

1.0

1.2

—

Allergic conjunctivitis

364

1.32

1.11

1.2

1.1

—

Other complications of surgical and medical care, not elsewhere classified

1.96

1.11

1.2

1.1

—

Fracture of foot, except ankle

135

1.56

1.11

1.2

1.1

—

Basal cell carcinoma, including Hilmo

208

1.37

1.11

1.2

—

1.78

1.10

1.3

1.1

—

Excessive, frequent and irregular menstruation

118

1.45

1.10

1.3

1.1

—

Calculus of kidney and ureter

184

1.47

1.10

1.1

1.2

—

Medicines for HER+ breast cancer

210

1.42

1.09

1.0

1.1

—

Kela-code for severe mental illness

226

1.42

1.09

1.1

—

Pustulosis palmaris et plantaris

2.38

1.09

1.0

1.3

—

Other diseases of peritoneum

2.38

1.09

1.0

1.4

—

Non-small cell lung cancer, squamous

2.38

1.09

1.2

1.1

—

Ingrowing nail

2.38

1.09

1.4

—

Maltreatment syndromes

2.38

1.09

1.4

1.2

—

Acute bronchitis

263

1.38

1.09

1.0

1.1

—

Acute and subacute iridocyclitis

104

1.64

1.09

1.2

—

Superficial injury of ankle and foot

1.82

1.08

1.2

1.1

—

Benign neoplasm: Choroid

1.95

1.08

1.1

1.2

—

L04AC Interleukin inhibitors

1.95

1.08

1.6

1.2

—

Infectious mononucleosis, including avohilmo

1.95

1.08

1.0

1.1

—

Infectious mononucleosis

1.95

1.08

1.0

1.1

—

Dermatophytosis

1.73

1.08

1.1

1.2

—

Any event in cancer register

369

1.25

1.08

1.1

1.2

—

Gestational [pregnancy-induced] hypertension

140

0.50

1.08

1.3

1.1

—

Effects of foreign body entering through natural orifice

144

1.53

1.08

1.0

1.2

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

2.19

1.08

1.0

1.2

—

Unspecified mental disorder

252

1.39

1.07

1.1

—

Fracture of lower leg, including ankle

357

1.32

1.07

1.1

—

Other disorders of cornea

1.87

1.07

1.1

1.2

—

Chalazion

1.87

1.07

1.4

1.1

—

Fracture of lumbar spine and pelvis

128

1.56

1.07

1.0

1.2

—

Other diseases of anus and rectum

193

1.45

1.06

1.2

1.1

—

Other arrhythmias

336

1.29

1.06

1.0

1.1

—

Allergic rhinitis

176

1.46

1.04

1.2

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

355

1.31

1.03

1.2

1.1

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

2.28

1.03

1.0

1.3

—

Abnormal findings on examination of urine, without diagnosis

2.28

1.03

1.0

1.3

—

Femoral hernia

2.28

1.03

1.0

1.3

—

Other endocrine disorders

2.28

1.03

1.4

1.2

—

259

1.35

1.03

1.2

1.1

—

Congenital malformations of the circulatory system

1.70

1.03

1.1

—

Other diseases of intestine

1.63

1.03

1.3

1.2

—

Conduction disorders

169

1.42

1.03

1.1

1.2

—

Postmenopausal osteoporosis with pathological fracture

2.06

1.03

1.1

—

Scleritis and episcleritis

2.06

1.03

1.1

1.2

—

Mental and behavioural disorders due to sedatives or hypnotics

2.06

1.03

1.1

1.2

—

Benign neoplasm: Skin of other and unspecified parts of face

1.84

1.02

1.0

1.2

—

Inflammatory disease of uterus

1.73

1.02

1.2

1.1

—

Cholecystitis

1.73

1.02

1.0

1.2

—

Malignant neoplasm of breast, HER2-negative

157

1.40

1.02

1.0

1.2

—

Benign neoplasm: Adrenal gland

1.92

1.02

1.1

1.2

—

Conductive hearing loss, unspecified

1.92

1.02

1.1

1.2

—

Vestibular neuronitis

1.89

1.01

1.0

1.2

—

Caries of dentine, including avohilmo

280

1.26

1.00

1.2

1.1

—

Bitten or struck by other mammals

1.77

1.00

1.1

1.2

—

Excessive vomiting in pregnancy

1.88

1.00

1.6

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1.88

1.00

1.2

—

Peripheral arterial reconstruction

1.65

1.00

1.0

1.2

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

229

0.67

1.00

1.1

—

L01XX Other antineoplastic agents

2.00

1.00

1.6

1.2

—

Calcific tendinitis of shoulder

2.00

1.00

1.6

1.2

—

Other inflammatory liver diseases

2.00

1.00

1.3

1.2

—

Appendicitis, broad definition

473

1.25

0.99

1.1

1.2

—

Fracture of femur

147

1.47

0.99

1.1

1.2

—

Glucagon-like peptide-1 (GLP-1) analogues

197

1.42

0.99

1.3

1.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

197

1.42

0.99

1.3

1.2

—

Benign lipomatous neoplasm of other sites/unspecified

1.84

0.98

1.3

1.2

—

Complications following abortion and ectopic and molar pregnancy

2.18

0.98

1.0

1.3

—

Clear cell adenocarcinoma of kidney

2.18

0.98

1.2

1.3

—

Mandibular retrognathia

0.00

0.97

0.0

1.3

—

Colorectal cancer

134

1.50

0.97

1.1

1.2

—

Thrombocytopenia, unspecified

1.95

0.97

1.0

1.2

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

1.95

0.97

1.0

1.2

—

Hypermetropia

1.94

0.97

1.3

1.2

—

Acute alcohol intoxication, ICD10

132

1.52

0.96

1.1

1.2

—

Nail disorders

1.80

0.96

1.4

1.2

—

Actinic keratosis

234

1.36

0.96

1.2

1.1

—

Squamous cell neoplasms and carcinomas of the skin

1.80

0.96

1.2

1.1

—

Ulcerative proctitis

0.00

0.96

0.0

1.2

—

Haemorrhage from respiratory passages

205

1.38

0.96

1.1

1.2

—

Diseases of appendix

474

1.24

0.96

1.1

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

155

1.47

0.95

1.2

1.1

—

Hypertensive Heart Disease

118

1.48

0.95

1.0

1.1

—

Postpartum hemorraghe, all women as controls

129

1.51

0.95

1.1

—

Chronic lower respiratory diseases

110

487

1.19

0.95

1.3

1.1

—

Disturbance of activity and attention

1.84

0.94

1.1

1.2

—

Atopic dermatitis, strict definition

170

1.44

0.94

1.1

—

Other noninflammatory disorders of vulva and perineum

1.77

0.94

1.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

2.27

0.94

1.3

1.1

—

Asthma-related pneumonia or sepsis

241

1.36

0.94

1.3

1.1

—

Asthma, hospital admissions 3, pneumonia

241

1.36

0.94

1.3

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

242

1.36

0.94

1.2

—

Unspecified privation

1.78

0.94

1.1

1.2

—

Burns and corrosions of external body surface, specified by site

1.78

0.94

1.1

1.2

—

Malignant neoplasm of colon

1.65

0.94

1.1

1.2

—

Endometriosis of pelvic peritoneum

1.65

0.94

1.1

—

Atrial fibrillation and flutter

1.49

0.94

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

312

1.29

0.94

1.3

1.1

—

Malignant neoplasm of skin, including Hilmo

236

1.31

0.93

1.2

—

Other acquired deformities of musculoskeletal system and connective tissue

2.23

0.93

1.0

1.3

—

Caught, crushed, jammed or pinched in or between objects

2.23

0.93

1.0

1.2

—

Sequelae of other external causes

2.23

0.93

1.0

1.3

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

2.22

0.93

1.0

1.2

—

Fenamates

1.70

0.92

1.2

—

117

1.52

0.91

1.1

—

Lesion of lateral popliteal nerve

2.15

0.91

1.3

1.2

—

Acute lymphadenitis

2.15

0.91

1.0

1.3

—

Congenital malformations of eye, ear, face and neck

2.14

0.91

1.0

1.2

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS